[ad_1]
With the earnings season on the way, there are now some stocks and sectors on Wall Street recommended by Goldman Sachs.
The sector to invest in now
What we are experiencing is an extremely difficult environment, as we have not seen in decades, for anyone who wants to invest in the stock markets. In fact, to be precise, it’s a cryptic picture for anyone who wants to trade any asset. Especially how and where to put the money to keep them safe. Therefore, it is easy to understand why investors have focused for the most part on health and technology stocks. The sector to invest in now is that of biotechnology. At least as advised by Goldman Sachs analysts who suggest buying specific stocks in the biotech sector.
Titles and sectors recommended by Goldman Sachs now
Proof of the goodness of choice also comes from the fact that the health sector is one of the best performers for this 2020 in the s & p 500. At the top of the ranking, in particular, there are companies in the biotechnology sector. The reason is easily understood. Most of them decided to invest in research for a Covid 19 vaccine. The problem now is finding out who will win the race. In fact, after an initial hesitation, the field has become very crowded and there are now many molecules and drugs waiting to be approved by the supervisory authorities. That said, what are the stocks and sectors recommended by Goldman Sachs now.
How to minimize the risk?
What does this mean? That all companies that try but fail will be eliminated precisely because of high expectations. And it is in this scenario that the new Goldman Sachs report is inserted. How to minimize the risk? Analysts suggest investing in leading large-cap companies. Goldman Sachs’ list of the best stocks to buy BioMarin Pharmaceuticals Inc. has been in the spotlight for some time. Goldman Sachs’ stock price target is $ 162 with the consensus that on Wall Street it is well below $ 117.64.